Alyeska Investment Group’s 89bio ETNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.67M Sell
576,973
-275,254
-32% -$2.7M 0.02% 407
2025
Q1
$6.2M Sell
852,227
-73,170
-8% -$532K 0.02% 346
2024
Q4
$7.24M Buy
925,397
+116,833
+14% +$914K 0.03% 374
2024
Q3
$5.98M Buy
808,564
+8,564
+1% +$63.4K 0.03% 333
2024
Q2
$6.41M Buy
800,000
+500,000
+167% +$4.01M 0.04% 307
2024
Q1
$3.49M Sell
300,000
-283,187
-49% -$3.3M 0.02% 341
2023
Q4
$6.51M Buy
583,187
+123,300
+27% +$1.38M 0.04% 287
2023
Q3
$7.1M Buy
459,887
+125,000
+37% +$1.93M 0.05% 312
2023
Q2
$6.35M Buy
334,887
+1,402
+0.4% +$26.6K 0.05% 303
2023
Q1
$5.08M Buy
+333,485
New +$5.08M 0.04% 295
2022
Q3
Sell
-300,000
Closed -$966K 406
2022
Q2
$966K Buy
+300,000
New +$966K 0.01% 497
2021
Q4
Sell
-51,705
Closed -$1.01M 645
2021
Q3
$1.01M Buy
51,705
+2,300
+5% +$45.1K 0.01% 574
2021
Q2
$924K Hold
49,405
0.01% 613
2021
Q1
$1.17M Sell
49,405
-25,000
-34% -$592K 0.02% 533
2020
Q4
$1.81M Sell
74,405
-7,971
-10% -$194K 0.03% 373
2020
Q3
$2.11M Buy
+82,376
New +$2.11M 0.03% 343
2020
Q1
Sell
-119,444
Closed -$3.14M 372
2019
Q4
$3.14M Buy
+119,444
New +$3.14M 0.04% 245